Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug DiscoveryGlobeNewsWire • 02/13/26
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug DiscoveryGlobeNewsWire • 09/19/25
Sonoro Energy, Advanced BioCatalytics, and NexTier Energy Launch Strategic Collaboration to Advance Heavy Oil Recovery from Carbonate Reservoirs in the Middle EastTheNewswire • 05/05/25
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public OfferingGlobeNewsWire • 03/07/25
Advanced Biomed sets IPO terms, which could value the biotech at up to $625 millionMarket Watch • 07/19/23